Global Plasma Fractionation Market was valued at USD 30.84 Bn. in 2023. Global Plasma Fractionation Market size is expected to grow at a CAGR of 6.89 % through the forecast period.Market Overview:
Plasma fractionation is the post-processing step after donor-obtained plasma. Blood's fluid component, plasma, is fractionated to produce various plasma derivatives, including albumin and immunoglobulins. These plasma-derived compounds are used to treat a variety of blood plasma-related diseases and have therapeutic effects.To know about the Research Methodology :- Request Free Sample Report Immunoglobulins can help cure autoimmune disorders and boost the immune system. Blood disorders like haemophilia are treated with clotting factors, and albumins are helpful when albumin levels are low or when there has been fluid loss. The report explores the Plasma Fractionation Market's segments (Connectivity and Content, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2023. The report investigates the Plasma Fractionation Market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Plasma Fractionation Market's contemporary competitive scenarioDynamics:
The main driver of the plasma fractionation market's growth is the rise in the number of elderly people around the world, who are more likely to have rare diseases that call for the usage of plasma derivatives. Utilization of plasma-derived immunoglobulins in numerous therapeutic indications, such as autoimmune and inflammatory illnesses, is rising. The increased use of immunoglobulins and alpha-1-antitrypsin in various branches of medicine around the world also contributes to the market's expansion for plasma fractionation. Increased lung-infecting respiratory illnesses are present in the COVID-19 scenario. Diabetes and high blood pressure are problems for some patients, and family history often has a big impact. Therefore, plasma fractionation is often used to treat the condition. Another significant element that boosts the market's expansion is the increase of plasma collection facilities around the world. The government's positive support for raising public knowledge about the use of plasma-derived goods also contributes to the market's expansion.Plasma Fractionation Market Segment Analysis:
Based on the product type plasma fractionation market is segmented into Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others. The plasma fractionation market for immunoglobulin is the largest and is anticipated to increase at the fastest rate over the prediction period. The usage of immunoglobulins in a variety of conditions, including autoimmune diseases, inflammatory diseases, and primary and secondary immunological deficiencies, has contributed to the expansion of this market. Another factor driving the expansion of the immunoglobulin market is the spike in immunology-related research taking place all over the world. Based on the application plasma fractionation market is segmented into Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology, and Others. Immunology has the largest market share owing to factors such as the increasing usage of plasma proteins in the treatment of immune deficiencies. Based on the end-user market is segmented into Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others. Hospitals & clinics have the largest market share due to improving infrastructure and healthcare facilities provided by hospitals, along with increasing off-label use of plasma fractionated products in hospitals to treat various diseases.Regional Insights:
The market for plasma fractionation in North America is dominated by the region with the highest CAGR in the global plasma fractionation market because residents there are more aware of the broad benefits of plasma and because the prevalence of respiratory disorders is on the rise. Additionally, the existence of important players, an increase in plasma collection facilities, an increase in immunoglobulin consumption, and the capacity to supply plasma due to the viability of plasma collection & distribution all contribute to the regional market's growth. Asia-Pacific is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of the Asia-Pacific market are the rising consumption of plasma-derived products, the strategic developments made by the companies in this region, the presence of leading players, and contract fractionation agreements between the countries. Europe is also the dominating market due to the geriatric population and immune deficiency diseases.Plasma Fractionation Industry Ecosystem: -
Plasma Fractionation Market Scope: Inquire before buying
Global Plasma Fractionation Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 30.84 Bn. Forecast Period 2024 to 2030 CAGR: 6.89% Market Size in 2030: USD 49.18 Bn. Segments Covered: by Type Immunoglobulins Coagulation Factor Concentrates Albumin Protease Inhibitors Other by Application Immunology Hematology Neurology Critical Care Hemato-Oncology Rheumatology Others by End User Hospitals & Clinics Clinical Research Laboratories Academic Institutions Others Plasma Fractionation Market by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Plasma Fractionation Market, Key Players
1.io Products Laboratory 2.iotest AG 3.hina Biologic Products Holdings Inc. 4.SL Limited 5.reen Cross Corporation 6.rifols 7.apan Blood Products Organization 8.edrion 9.FB group 10.Octapharma AG 11.Sanquin Blood Supply Foundation 12.Takeda Pharmaceutical Company Limited. 13.Baxter 14.Green Cross Corporation 15.Shanghai RAAS 16.Bharat Serums and Vaccines Limited 17.Merck KGaA 18.ADMA Biologics 19.Boccard 20.Intas Pharmaceuticals Ltd. Frequently Asked Questions: 1. Which region has the largest share in Global Market? Ans: North America region held the highest share in 2023. 2. What is the growth rate of Global Market? Ans: The Global Market is growing at a CAGR of 7.6% during forecasting period 2024-2030. 3. What is scope of the Global Market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this Market? Ans: The Global Market is studied from 2023 to 2030.
1. Plasma Fractionation Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Plasma Fractionation Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Business Segment 2.4.3. End-user Segment 2.4.4. Growth Rate (Y-O-Y %) 2.4.5. Revenue (2023) 2.4.6. Profit Margin 2.4.7. Market Share 2.4.8. Key Development 2.5. Market Size Estimation Methodology 2.5.1. Bottom-Up Approach 2.5.2. Top-Down Approach 2.6. Industry Ecosystem 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Mergers and Acquisitions Details 3. Plasma Fractionation Market: Dynamics 3.1. Plasma Fractionation Market Trends 3.2. Plasma Fractionation Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Customer Bargaining Power 3.3.2. Supplier Bargaining Power 3.3.3. Threat of New Entrants 3.3.4. Rivalry of Competitors 3.3.5. Threat of Substitute Products 3.4. PESTLE Analysis 3.5. Value Chain Analysis 3.6. Supply Chain Analysis 3.7. Regulatory Landscape By Region 3.7.1. Regulations Related to Plasma Fractionation Market 3.7.2. Regulatory Bodies, Government Agencies, and Other Organizations 3.8. Key Opinion Leader Analysis for the Plasma Fractionation Industry 3.9. Price Analysis 3.9.1. Average Selling Price of Plasma Fractionation Products, By Key Players 3.9.2. Average Selling Price of Plasma Fractionation Products, By Region 3.10. Patent Analysis 3.10.1. Key Companies with the Highest number of Patents 3.10.2. Patent Registration Analysis 3.10.3. Number of Patents Granted Still 2024 3.10.4. Legal Status of Patents Field in Plasma Fractionation Market 3.11. Technology Analysis 3.11.1. Cohn’s Cold Ethanol Plasma Fractionation 3.11.2. Gel Filtration Plasma Fractionation 3.11.3. Human Plasma Fractionation By Polyethylene Glycol 3.11.4. Plasma Fractionation By Ammonium Sulfate 3.11.5. Depth Filtration Plasma Fractionation 3.11.6. Plasma Fractionation By Chromatography 3.12. Investment and Funding Scenario 4. Plasma Fractionation Market: Global Market Size and Forecast By Segmentation (By Value in USD Mn) (2023-2030) 4.1. Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 4.1.1. Immunoglobulins 4.1.2. Coagulation Factor Concentrates 4.1.3. Albumin 4.1.4. Protease Inhibitors 4.1.5. Other 4.2. Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 4.2.1. Immunology 4.2.2. Hematology 4.2.3. Neurology 4.2.4. Critical Care 4.2.5. Hemato-Oncology 4.2.6. Rheumatology 4.2.7. Others 4.3. Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 4.3.1. Hospitals & Clinics 4.3.2. Clinical Research Laboratories 4.3.3. Academic Institutions 4.3.4. Others 5. North America Plasma Fractionation Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 5.1. North America Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 5.1.1. Immunoglobulins 5.1.2. Coagulation Factor Concentrates 5.1.3. Albumin 5.1.4. Protease Inhibitors 5.1.5. Other 5.2. North America Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 5.2.1. Immunology 5.2.2. Hematology 5.2.3. Neurology 5.2.4. Critical Care 5.2.5. Hemato-Oncology 5.2.6. Rheumatology 5.2.7. Others 5.3. North America Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 5.3.1. Hospitals & Clinics 5.3.2. Clinical Research Laboratories 5.3.3. Academic Institutions 5.3.4. Others 5.4. North America Plasma Fractionation Market Size and Forecast, By Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 5.4.1.1.1. Immunoglobulins 5.4.1.1.2. Coagulation Factor Concentrates 5.4.1.1.3. Albumin 5.4.1.1.4. Protease Inhibitors 5.4.1.1.5. Other 5.4.1.2. United States Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 5.4.1.2.1. Immunology 5.4.1.2.2. Hematology 5.4.1.2.3. Neurology 5.4.1.2.4. Critical Care 5.4.1.2.5. Hemato-Oncology 5.4.1.2.6. Rheumatology 5.4.1.2.7. Others 5.4.1.3. United States Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 5.4.1.3.1. Hospitals & Clinics 5.4.1.3.2. Clinical Research Laboratories 5.4.1.3.3. Academic Institutions 5.4.1.3.4. Others 5.4.2. Canada 5.4.2.1. Canada Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 5.4.2.1.1. Immunoglobulins 5.4.2.1.2. Coagulation Factor Concentrates 5.4.2.1.3. Albumin 5.4.2.1.4. Protease Inhibitors 5.4.2.1.5. Other 5.4.2.2. Canada Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 5.4.2.2.1. Immunology 5.4.2.2.2. Hematology 5.4.2.2.3. Neurology 5.4.2.2.4. Critical Care 5.4.2.2.5. Hemato-Oncology 5.4.2.2.6. Rheumatology 5.4.2.2.7. Others 5.4.2.3. Canada Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 5.4.2.3.1. Hospitals & Clinics 5.4.2.3.2. Clinical Research Laboratories 5.4.2.3.3. Academic Institutions 5.4.2.3.4. Others 5.4.3. Mexico 5.4.3.1. Mexico Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 5.4.3.1.1. Immunoglobulins 5.4.3.1.2. Coagulation Factor Concentrates 5.4.3.1.3. Albumin 5.4.3.1.4. Protease Inhibitors 5.4.3.1.5. Other 5.4.3.2. Mexico Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 5.4.3.2.1. Immunology 5.4.3.2.2. Hematology 5.4.3.2.3. Neurology 5.4.3.2.4. Critical Care 5.4.3.2.5. Hemato-Oncology 5.4.3.2.6. Rheumatology 5.4.3.2.7. Others 5.4.3.3. Mexico Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 5.4.3.3.1. Hospitals & Clinics 5.4.3.3.2. Clinical Research Laboratories 5.4.3.3.3. Academic Institutions 5.4.3.3.4. Others 6. Europe Plasma Fractionation Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 6.1. Europe Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.2. Europe Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.3. Europe Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 6.4. Europe Plasma Fractionation Market Size and Forecast, By Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.4.1.2. United Kingdom Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.4.1.3. United Kingdom Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 6.4.2. France 6.4.2.1. France Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.4.2.2. France Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.4.2.3. France Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.4.3.2. Germany Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.4.3.3. Germany Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.4.4.2. Italy Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.4.4.3. Italy Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.4.5.2. Spain Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.4.5.3. Spain Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.4.6.2. Sweden Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.4.6.3. Sweden Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.4.7.2. Austria Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.4.7.3. Austria Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 6.4.8.2. Rest of Europe Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 6.4.8.3. Rest of Europe Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7. Asia Pacific Plasma Fractionation Market Size and Forecast by Segmentation (By Value in USD Million) (2023-2030) 7.1. Asia Pacific Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.2. Asia Pacific Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.3. Asia Pacific Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4. Asia Pacific Plasma Fractionation Market Size and Forecast, By Country (2023-2030) 7.4.1. China 7.4.1.1. China Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.1.2. China Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.1.3. China Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.2.2. S Korea Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.2.3. S Korea Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.3.2. Japan Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.3.3. Japan Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.4. India 7.4.4.1. India Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.4.2. India Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.4.3. India Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.5.2. Australia Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.5.3. Australia Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.6.2. Indonesia Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.6.3. Indonesia Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.7.2. Malaysia Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.7.3. Malaysia Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.8.2. Vietnam Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.8.3. Vietnam Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.9.2. Taiwan Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.9.3. Taiwan Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 7.4.10.2. Rest of Asia Pacific Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 7.4.10.3. Rest of Asia Pacific Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 8. South America Plasma Fractionation Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 8.1. South America Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 8.2. South America Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 8.3. South America Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 8.4. South America Plasma Fractionation Market Size and Forecast, By Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 8.4.1.2. Brazil Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 8.4.1.3. Brazil Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 8.4.2.2. Argentina Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 8.4.2.3. Argentina Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest of South America Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 8.4.3.2. Rest of South America Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 8.4.3.3. Rest of South America Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 9. Middle East and Africa Plasma Fractionation Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 9.1. Middle East and Africa Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 9.2. Middle East and Africa Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 9.3. Middle East and Africa Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 9.4. Middle East and Africa Plasma Fractionation Market Size and Forecast, By Country (2023-2030) 9.4.1. South Africa 9.4.1.1. South Africa Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 9.4.1.2. South Africa Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 9.4.1.3. South Africa Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 9.4.2. GCC 9.4.2.1. GCC Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 9.4.2.2. GCC Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 9.4.2.3. GCC Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 9.4.3. Rest Of MEA 9.4.3.1. Rest Of MEA Plasma Fractionation Market Size and Forecast, By Type (2023-2030) 9.4.3.2. Rest Of MEA Plasma Fractionation Market Size and Forecast, By Application (2023-2030) 9.4.3.3. Rest Of MEA Plasma Fractionation Market Size and Forecast, By End-Use (2023-2030) 10. Company Profile: Key Players 10.1. Bio Products Laboratory 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview (Total Revenue, Segment Revenue, and Regional Revenue) 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Iotest AG 10.3. Hina Biologic Products Holdings Inc. 10.4. SL Limited 10.5. Reen Cross Corporation 10.6. Rifols 10.7. Apan Blood Products Organization 10.8. Edrion 10.9. FB group 10.10. Octapharma AG 10.11. Sanquin Blood Supply Foundation 10.12. Takeda Pharmaceutical Company Limited. 10.13. Baxter 10.14. Green Cross Corporation 10.15. Shanghai RAAS 10.16. Bharat Serums and Vaccines Limited 10.17. Merck KGaA 10.18. ADMA Biologics 10.19. Boccard 10.20. Intas Pharmaceuticals Ltd. 11. Key Findings 12. Analyst Recommendations 12.1. Attractive Opportunities for Players in the Plasma Fractionation Market 12.2. Future Outlooks 13. Plasma Fractionation Market: Research Methodology